Skip to main content
. 2012 Dec 5;11:402. doi: 10.1186/1475-2875-11-402

Figure 5.

Figure 5

Use of different ASAQ forms (upper panel) and risk of TESS with over-dosing (bottom panel) expressed as OR (95%CIs).